MedTrace Logo

Predictors of Pulmonary Hypertension in Patients With Advanced Lung Diseases

NCT02777957 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2020-05-27

No results posted yet for this study

Summary

First, the aim of the study was to evaluate the usefulness of echocardiographic parameters for detecting pulmonary hypertension (PH) in patients with advanced lung disease referred for lung transplantation. Second, to assess the prevalence of PH and to identify which hemodynamic, echocardiographic, pulmonary functional test, exercise capacity and biochemical parameters (especially NT-proBNP) have an impact on survival in a cohort of patients with severe lung diseases referred for lung transplantation.

Conditions

  • Pulmonary Hypertension

Sponsors & Collaborators

  • Silesian Centre for Heart Diseases

    lead OTHER

Principal Investigators

  • Jolanta Nowak, MD, PhD · 3rd Department of Cardiology, Silesian Centre for Heart Diseases

  • Mariusz Gasior, Prof., PhD · 3rd Department of Cardiology, Silesian Centre for Heart Diseases

  • Slawomir Zeglen, MD, PhD · Departament of Cardiac Surgery and Transplantology, Silesian Centre for Heart Diseases

  • Jacek Wojarski, MD, PhD · Departament of Cardiac Surgery and Transplantology, Silesian Centre for Heart Diseases

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2020-04-30
Completion
2023-04-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02777957 on ClinicalTrials.gov